NCT06943612

Brief Summary

COLOSARC-Q is a multicenter study with the objective of providing an up-to-date assessment of colorectal resections and reconstruction techniques in the context of multivisceral resections for retroperitoneal sarcomas, as well as colorectal surgery-associated complications and their impact on patients' quality of life. In multivisceral resections involving the colon and rectum, the primary aim is to achieve complete resection and preserve organ function. However, multivisceral resections have a high risk of perioperative morbidity including anastomotic leakage. The proposed project aims to determine the number of primary anastomoses, their insufficiency rates, and the fraction of patients with primary and secondary stomas. In addition, the patients' quality of life after multivisceral sarcoma resection is to be recorded using standardized surveys. The analysis has the potential to facilitate intraoperative decision-making for colorectal resections in the context of multivisceral resections.

Trial Health

60
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2025

Geographic Reach
2 countries

13 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 27, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 10, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 24, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

December 12, 2025

Status Verified

December 1, 2025

Enrollment Period

1.1 years

First QC Date

April 10, 2025

Last Update Submit

December 4, 2025

Conditions

Keywords

Soft tissue sarcomaRetroperitoneal SarcomaSarcoma SurgeryStomaColorectal resection

Outcome Measures

Primary Outcomes (1)

  • Evaluation of resection and reconstruction procedures of the colon and rectum in the context of multivisceral resections of retroperitoneal sarcomas

    Description of the surgical procedure, e.g. righ hemicolectomy with primary anastomosis

    immediately after the surgery

Secondary Outcomes (5)

  • Postoperative complications associated with resections and reconstructions of the bowel

    up to 90 days after surgery

  • Assessment of quality of life after colorectal resections in the context of RPS resections

    through study completion, an average of 1 year

  • Assessment of changes in bowel function after resection of retroperitoneal sarcomas

    through study completion, an average of 1 year

  • Identification of problems and needs of RPS patients

    through study completion, an average of 1 year

  • Determination of patient-, tumor- and treatment-related factors influencing the above-mentioned primary and secondary study objectives

    through study completion, an average of 1 year

Study Arms (1)

Patients with primary, retroperitoneal sarcomas who underwent surgery with colorectal resection

Patients with primary retroperitoneal sarcomas who underwent surgery with colorectal resection at DKG-certified sarcoma centers or hospitals in Germany and Switzerland that meet certification-equivalent criteria

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with primary, retroperitoneal sarcomas who underwent surgery with colorectal resection at DKG-certified sarcoma centers or hospitals in Germany and Switzerland that meet certification-equivalent criteria.

You may qualify if:

  • Histological confirmation with evidence of a retroperitoneal sarcoma
  • Tumor resection with colorectal resection
  • Surgery in a DKG-certified sarcoma center or hospital that meets certification-equivalent criteria
  • Age 18 years or older
  • Written consent

You may not qualify if:

  • Absence of consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (13)

Sarcoma Center of University Medical Center Mannheim

Mannheim, Baden-Wurttemberg, 68167, Germany

RECRUITING

Helios Hospital Berlin-Buch

Berlin, Germany

RECRUITING

University Medical Center Dresden

Dresden, Germany

RECRUITING

University Medical Center Erlangen

Erlangen, Germany

RECRUITING

University Medical Center Halle

Halle, Germany

RECRUITING

University Medical Center Hamburg-Eppendorf

Hamburg, Germany

RECRUITING

Medical University of Hannover

Hanover, Germany

RECRUITING

Heidelberg University Hospital

Heidelberg, Germany

RECRUITING

University Hospital Magdeburg

Magdeburg, Germany

RECRUITING

LMU Hospital

München, Germany

RECRUITING

University Medical Center Tübingen

Tübingen, Germany

RECRUITING

University Medical Center Ulm

Ulm, Germany

RECRUITING

Sarcoma Center University of Basel

Basel, Switzerland

RECRUITING

Related Publications (5)

  • Jakob J, Hentschel L, Richter S, Kreisel I, Hohenberger P, Kasper B, Andreou D, Pink D, Schmitt J, Schuler MK, Eichler M. Transferability of Health-Related Quality of Life Data of Large Observational Studies to Clinical Practice: Comparing Retroperitoneal Sarcoma Patients from the PROSa Study to a TARPS-WG Cohort. Oncol Res Treat. 2022;45(11):660-669. doi: 10.1159/000525288. Epub 2022 Jun 14.

    PMID: 35700716BACKGROUND
  • MacNeill AJ, Fiore M. Surgical morbidity in retroperitoneal sarcoma resection. J Surg Oncol. 2018 Jan;117(1):56-61. doi: 10.1002/jso.24902. Epub 2018 Jan 3.

    PMID: 29314041BACKGROUND
  • Bonvalot S, Raut CP, Pollock RE, Rutkowski P, Strauss DC, Hayes AJ, Van Coevorden F, Fiore M, Stoeckle E, Hohenberger P, Gronchi A. Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG. Ann Surg Oncol. 2012 Sep;19(9):2981-91. doi: 10.1245/s10434-012-2342-2. Epub 2012 Apr 3.

    PMID: 22476756BACKGROUND
  • Gronchi A, Strauss DC, Miceli R, Bonvalot S, Swallow CJ, Hohenberger P, Van Coevorden F, Rutkowski P, Callegaro D, Hayes AJ, Honore C, Fairweather M, Cannell A, Jakob J, Haas RL, Szacht M, Fiore M, Casali PG, Pollock RE, Raut CP. Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group. Ann Surg. 2016 May;263(5):1002-9. doi: 10.1097/SLA.0000000000001447.

    PMID: 26727100BACKGROUND
  • Hettler M, Scharpf KR, Eich A, Albertsmeier M, Dupree A, Hetjens S, Harbrucker M, Menge F, Betzler A, Hohenberger P, Jakob J. Multicentre prospective non-interventional study protocol for evaluating surgical strategies for Colorectal Resections and Postoperative Quality of Life in Retroperitoneal Sarcoma Patients Across German-Speaking Sarcoma Centres (COLOSARC-Q). BMJ Open. 2025 Dec 30;15(12):e102015. doi: 10.1136/bmjopen-2025-102015.

Related Links

MeSH Terms

Conditions

Sarcoma

Condition Hierarchy (Ancestors)

Neoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasms

Study Officials

  • Jens Jakob, Prof.

    Sarcoma Unit, Department of Surgery, University Medical Center Mannheim, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jens Jakob, Prof.

CONTACT

Madelaine Hettler, Dr.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head Sarcoma Surgery and Sarcoma Center Mannheim, Heidelberg University

Study Record Dates

First Submitted

April 10, 2025

First Posted

April 24, 2025

Study Start

January 27, 2025

Primary Completion

March 1, 2026

Study Completion

March 1, 2026

Last Updated

December 12, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations